ADA-friendly PDF: The ODYSSEY OUTCOMES Trial: Topline Results: Alirocumab in Patients After Acute Coronary Syndrome

The ODYSSEY OUTCOMES Trial—Topline Results: Alirocumab in Patients After Acute Coronary Syndrome